Preventing Overdose Using Information and Data From the Environment
PROVIDENT
Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial
2 other identifiers
interventional
39
1 country
1
Brief Summary
The objectives of this project are to leverage surveillance data to predict future overdose outbreaks, and to evaluate the impact of a randomized, statewide, community-level intervention trial to target overdose prevention programs to neighborhoods at highest risk of future overdose deaths. This study develops and tests an opioid overdose forecasting tool, which will allow other states to identify and deploy interventions to communities at highest risk of opioid-related death. The findings from this study have the potential to significantly improve the allocation of resources to curb the opioid overdose epidemic in the United States.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
October 27, 2021
CompletedStudy Start
First participant enrolled
November 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2024
CompletedResults Posted
Study results publicly available
April 9, 2026
CompletedApril 9, 2026
November 1, 2025
2.8 years
October 15, 2021
October 21, 2025
March 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cumulative Incidence of Accidental Fatal and Non-Fatal Drug Overdoses
The primary outcome is the cumulative incidence of fatal and non-fatal drug overdoses per 10,000 residents. Fatal overdoses will be defined as drug-related deaths deemed accidental by a state medical examiner. Non-fatal overdoses will be defined as emergency medical services (EMS) runs for suspected non-fatal opioid overdoses identified and classified by the Rhode Island Emergency Medical Services Information System (RI-EMSIS). Since patient outcomes are recorded, patients who did not survive or who were dead upon arrival will be excluded to avoid double-counting.
0.5 to 2.75 years following intervention, with assessment of primary outcome at 2.75 years
Other Outcomes (1)
Number of Participants Engaged in Implementation Activities
At the time of participation in implementation evaluation activities (surveys, focus groups, or interviews)
Study Arms (2)
Intervention
EXPERIMENTALWithin these cities/towns, the health department will work with stakeholders to prioritize overdose prevention interventions to neighborhoods with the highest probability of future overdose deaths, as predicted by the PROVIDENT model.
Control
NO INTERVENTIONCities/towns assigned to the control arm will continue to work with the health department and distribute these interventions at existing resource levels, but without receiving information on predicted probability of overdose risk for specific neighborhoods.
Interventions
Each of the state's 39 municipalities will be randomised to the intervention (PROVIDENT) or comparator condition. An interactive, web-based tool will be developed to visualize the PROVIDENT model predictions. Municipalities assigned to the treatment arm will receive neighborhood risk predictions from the PROVIDENT model, and state agencies and community-based organizations will direct resources to neighborhoods identified as high risk. Municipalities assigned to the control arm will continue to receive surveillance information and overdose prevention resources, but they will not receive neighborhood risk predictions from this study.
Eligibility Criteria
You may qualify if:
- \- Cities and towns in Rhode Island
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- University of California, Berkeleycollaborator
- National Institute on Drug Abuse (NIDA)collaborator
- NYU Langone Healthcollaborator
Study Sites (1)
Brown University School of Public Health
Providence, Rhode Island, 02912, United States
Related Publications (1)
Marshall BDL, Alexander-Scott N, Yedinak JL, Hallowell BD, Goedel WC, Allen B, Schell RC, Li Y, Krieger MS, Pratty C, Ahern J, Neill DB, Cerda M. Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trial. Addiction. 2022 Apr;117(4):1152-1162. doi: 10.1111/add.15731. Epub 2021 Nov 29.
PMID: 34729851DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Brandon DL Marshall
- Organization
- Brown University
Study Officials
- PRINCIPAL INVESTIGATOR
Brandon DL Marshall, PhD
Brown University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Modeling teams will be blinded to intervention control group assignment. All of the investigators on the modeling teams are blinded.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2021
First Posted
October 27, 2021
Study Start
November 15, 2021
Primary Completion
August 15, 2024
Study Completion
August 15, 2024
Last Updated
April 9, 2026
Results First Posted
April 9, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share